Diet Drug Qnexa Denied FDA Approval; Investors Not Worried
The data also showed a total body weight loss average of 10% in those taking Qnexa, which is a combination of the existing drugs phentermine and topiramate. … See all stories on this topic » |
TopNews United Kingdom |